ClinicalTrials.gg
Drug

Nirogacestat clinical trials

Also written PF-03084014 and Ogsiveo.

studies test it
24
open now
5
in phase 3
1
first study started
2009

How each study uses nirogacestat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the nirogacestat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
27 Nov 2023 · OGSIVEO · NDA 217677 (FDA, Drugs@FDA)
European Union
14 Aug 2025 · Ogsiveo · EMEA/H/C/006071 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Nirogacestat
12
Nirogacestat oral tablet
2

Brand

Ogsiveo
3

Development codes

PF-03084014
13

Studies by the year they started

24 studies that test it; most in 2015 (4)

Studies that test nirogacestat, by start year
YearStudies
20091
20132
20141
20154
20191
20203
20211
20224
20232
20241
20253
20261

By phase

A phase 1/2 study counts in both.

Phase 1
10
Phase 2
16
Phase 3
1
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 15 · Other 9

Pfizer (6) · SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany (5) · GlaxoSmithKline (3) · AIDS Malignancy Consortium (2) · Children's Oncology Group (1) · Memorial Sloan Kettering Cancer Center (1) · National Cancer Institute (NCI) (1) · Nam Bui (1)

Often tested with

Tested in the same studies.

Belantamab mafodotin (4) · Dexamethasone (3) · Pomalidomide (2) · Lenalidomide (2) · Famotidine (1) · Rabeprazole (1) · Elranatamab (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3

Studies that test nirogacestat.

Studies

Open first, then newest update. How each study uses nirogacestat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 24

See all 24 studies that test nirogacestat →

Given beside what is tested · 4 — nirogacestat is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with nirogacestat

What changed recently

From the registry's own updates since Oct 18, 2026.

Started recruiting1

Codes

What other systems call nirogacestat · ClinicalTrials.gg INT005668

  • MeSH (NLM) C550722nirogacestatConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) QZ62892OFJNIROGACESTATConfirmed FDA, NLM, Wikidata
  • Wikidata Q27088329nirogacestatConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C82383NirogacestatOne source FDA
  • DrugBank DB12005One source Wikidata

Also registered as nirogacestat hydrobromide (UNII 9T1XY6L45Y).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.